6 active trials 6 recruiting 1 Phase 3 19 disease areas 1 changes in 30 days
1 trial changed in the last 30 days: 0 stopped, 0 with notable changes, 1 with a minor change only.
Trial sites expanded: 37 → 40 locations
Nurix Therapeutics, Inc.Phase 2 NCT07221500 Registry history of NCT07221500 on ClinicalTrials.gov (opens the registry)
Updated
| Phase 1 | 3 | |
| Phase 1/2 | 1 | |
| Phase 2 | 1 | |
| Phase 3 | 1 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 3 | ||||
| NCT07516093 | Study of NX-5948 Versus Pirtobrutinib in R/R CLL/SLL | B-cell Lymphoma | Recruiting | 2026-08-31 |
| Phase 2 | ||||
| NCT07221500 | A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine… | Chronic Lymphocytic Leukemia (CLL) | Recruiting | 2026-09-17 |
| Phase 1/2 | ||||
| NCT07520006 | Study of NX-5948 in Combination With Other Agents in Adults With B-cell Malignancies | B-cell Lymphoma | Recruiting | 2026-08-28 |
| Phase 1 | ||||
| NCT05131022 | A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies | Chronic Lymphocytic Leukemia (CLL) | Recruiting | 2026-07-02 |
| NCT04830137 | A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies | Chronic Lymphocytic Leukemia (CLL) | Recruiting | 2026-03-20 |
| NCT05107674 | A Study of NX-1607 in Adults With Advanced Malignancies | Ovarian Cancer, Epithelial | Recruiting | 2025-09-09 |
Chronic Lymphocytic Leukemia (CLL) (5) · Leukemia (5) · Non-Hodgkin Lymphoma (5) · DLBCL (3) · Follicular Lymphoma (2) · Mantle Cell Lymphoma (2) · Bladder Cancer (1) · Breast Cancer (1) · Cervical Cancer (1) · Colorectal Cancer (1)